Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial (Q46443839)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial |
scientific article |
Statements
1 reference
Epirubicin increases long-term survival in adjuvant chemotherapy of patients with poor-prognosis, node-positive, early breast cancer: 10-year follow-up results of the French Adjuvant Study Group 05 randomized trial (English)
1 reference
Jacques Bonneterre
1 reference
Henri Roché
1 reference
Pierre Kerbrat
1 reference
Alain Brémond
1 reference
Pierre Fumoleau
1 reference
Moïse Namer
1 reference
Marie-Josèphe Goudier
1 reference
Simon Schraub
1 reference
Pierre Fargeot
1 reference
Isabelle Chapelle-Marcillac
1 reference
1 April 2005
1 reference
1 reference
23
1 reference
12
1 reference
2686-2693
1 reference
Identifiers
1 reference
1 reference